VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 189 filers reported holding VERACYTE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $183 | +44.1% | 8,174 | +64.3% | 0.00% | – |
Q2 2023 | $127 | +5.8% | 4,974 | -7.5% | 0.00% | – |
Q1 2023 | $120 | -3.2% | 5,377 | +3.2% | 0.00% | – |
Q4 2022 | $124 | -99.8% | 5,208 | +7.9% | 0.00% | – |
Q3 2022 | $80,000 | -12.1% | 4,827 | +5.1% | 0.00% | – |
Q2 2022 | $91,000 | -28.3% | 4,593 | +5.8% | 0.00% | – |
Q1 2022 | $127,000 | -25.3% | 4,343 | +5.2% | 0.00% | – |
Q4 2021 | $170,000 | -7.1% | 4,127 | +5.4% | 0.00% | – |
Q3 2021 | $183,000 | +17.3% | 3,916 | 0.0% | 0.00% | – |
Q2 2021 | $156,000 | -25.4% | 3,916 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $209,000 | +20.1% | 3,916 | +10.2% | 0.00% | – |
Q4 2020 | $174,000 | +51.3% | 3,555 | 0.0% | 0.00% | – |
Q3 2020 | $115,000 | +25.0% | 3,555 | 0.0% | 0.00% | – |
Q2 2020 | $92,000 | +5.7% | 3,555 | 0.0% | 0.00% | – |
Q1 2020 | $87,000 | -11.2% | 3,555 | 0.0% | 0.00% | – |
Q4 2019 | $98,000 | -8.4% | 3,555 | -5.4% | 0.00% | – |
Q2 2019 | $107,000 | – | 3,757 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |